Samuel Freyaldenhoven

Brigham and Women's Hospital

Papers

1

Total Citations

3

H-Index

1

About

Samuel Freyaldenhoven is a rising voice in thoracic oncology, whose work centers on advancing the diagnosis and staging of lung cancer through cutting-edge robotic technologies. His primary research focus lies at the intersection of interventional pulmonology and medical robotics, where he investigates how robotic bronchoscopy can overcome the limitations of traditional electromagnetic navigational bronchoscopy. Freyaldenhoven’s most cited paper, "Robotics in the diagnosis and staging of lung cancer" (2023), critically examines the diagnostic challenges of peripheral small lung lesions, noting that CT-guided biopsy remains superior to conventional navigational approaches. He argues that robotic bronchoscopy represents a potential breakthrough, offering enhanced stability and precision for sampling these difficult-to-reach nodules. While his citation count is still building—reflecting the early stage of his career—his work has already garnered attention for its timely focus on a pressing clinical problem. Freyaldenhoven’s contributions are particularly notable for bridging engineering innovation with bedside practice, positioning him as a promising researcher whose future work may help redefine standards for minimally invasive lung cancer diagnosis.

Research Focus

Key Achievements

1
H-Index
1
Papers
3
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
Robotics in the diagnosis and staging of lung cancer
3 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 1
🏛 Institutions: Brigham and Women's Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago